Greg Divis

(Gregory Divis Jr.)

Currently holds positions in Avadel Pharmaceuticals PLC, Jaguar Health Inc and Amag Pharma Usa Inc

Positions
Position Company Period
Chief Executive Officer, Chief Operating Officer, Executive Vice President, Director Avadel Pharmaceuticals PLC June 3, 2019 -
Director Jaguar Health Inc June 14, 2018 -
President, Chief Executive Officer, Director Amag Pharma Usa Inc Sept. 16, 2013 -
Interim Chief Executive Officer, Chief Operating Officer, Executive Vice President Avadel Pharmaceuticals PLC Jan. 1, 2019 - June 3, 2019
Chief Operating Officer, Chief Commercial Officer, Executive Vice President Avadel Pharmaceuticals PLC March 22, 2018 - Jan. 1, 2019
Executive Vice President, Chief Commercial Officer Avadel Pharmaceuticals PLC Jan. 1, 2017 - March 22, 2018
President, Chief Executive Officer Amag Pharma Usa Inc Nov. 17, 2010 - Sept. 16, 2013
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Total value Details
2023-08-10 2023-08-10
B Purchase
10,000 +6.7%
13.20
131,997 USD 		10,000 +6.7% 13.20 131,997 USD
2022-05-31 2022-05-27
B Purchase
50,000 +50.5%
2.05
102,500 USD 		50,000 +50.5% 2.05 102,500 USD
2020-08-13 2020-08-12
B Purchase
13,000 +15.1%
7.78
101,156 USD 		13,000 +15.1% 7.78 101,156 USD
2019-11-19 2019-11-15
B Purchase
19,000 +28.3%
5.13
97,470 USD 		19,000 +28.3% 5.13 97,470 USD
2018-06-27 2018-06-26
B Purchase
16,000 +48.3%
6.00
96,000 USD 		16,000 +48.3% 6.00 96,000 USD
2017-09-14 2017-09-12
B Purchase
10,600 +inf%
9.32
98,760 USD 		10,600 +inf% 9.32 98,760 USD